Yao Z - Search Results

1

Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.

Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET. Fu Z, et al. Among authors: yao z. Prostate. 2006 Feb 15;66(3):248-56. doi: 10.1002/pros.20319. Prostate. 2006. PMID: 16175585 Free article.

2

Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.

Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Fu Z, et al. Among authors: yao z. J Natl Cancer Inst. 2003 Jun 18;95(12):878-89. doi: 10.1093/jnci/95.12.878. J Natl Cancer Inst. 2003. PMID: 12813171

3

In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer.

Zhang J, Lu Y, Dai J, Yao Z, Kitazawa R, Kitazawa S, Zhao X, Hall DE, Pienta KJ, Keller ET. Zhang J, et al. Among authors: yao z. Prostate. 2004 Jun 1;59(4):360-9. doi: 10.1002/pros.20019. Prostate. 2004. PMID: 15065084 Free article.

4

Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.

Zhang J, Dai J, Yao Z, Lu Y, Dougall W, Keller ET. Zhang J, et al. Among authors: yao z. Cancer Res. 2003 Nov 15;63(22):7883-90. Cancer Res. 2003. PMID: 14633717

5

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.

Dai J, Kitagawa Y, Zhang J, Yao Z, Mizokami A, Cheng S, Nör J, McCauley LK, Taichman RS, Keller ET. Dai J, et al. Among authors: yao z. Cancer Res. 2004 Feb 1;64(3):994-9. doi: 10.1158/0008-5472.can-03-1382. Cancer Res. 2004. PMID: 14871830

6

Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.

Lu Y, Zhang J, Dai J, Dehne LA, Mizokami A, Yao Z, Keller ET. Lu Y, et al. Among authors: yao z. Clin Exp Metastasis. 2004;21(5):399-408. doi: 10.1007/s10585-005-0056-6. Clin Exp Metastasis. 2004. PMID: 15672864 Free article.

7

Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.

Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET. Dai J, et al. Among authors: yao z. Cancer Res. 2005 Sep 15;65(18):8274-85. doi: 10.1158/0008-5472.CAN-05-1891. Cancer Res. 2005. PMID: 16166304

8

Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.

Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z, Keller ET. Kitagawa Y, et al. Among authors: yao z. Cancer Res. 2005 Dec 1;65(23):10921-9. doi: 10.1158/0008-5472.CAN-05-1809. Cancer Res. 2005. PMID: 16322239

9

ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.

Yu C, Yao Z, Dai J, Zhang H, Escara-Wilke J, Zhang X, Keller ET. Yu C, et al. Among authors: yao z. In Vivo. 2011 Jan-Feb;25(1):69-76. In Vivo. 2011. PMID: 21282737

10

Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.

Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET. Wallner L, et al. Among authors: yao z. Cancer Res. 2006 Mar 15;66(6):3087-95. doi: 10.1158/0008-5472.CAN-05-3447. Cancer Res. 2006. PMID: 16540658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,435 results

Search Page

Filters